Injective (INJ)marks its 5th anniversary with $12.86B traded onchain, EVM integration, and institutional adoption, reshaping its blockchain ecosystem.
Injective (INJ)celebrated its fifth mainnet anniversary on November 8, 2026, highlighting a transformative year for the blockchain platform. Since its launch in 2021, Injective has evolved into a finance-focused layer-one blockchain supporting onchain trading of cryptocurrencies, tokenized stocks, FX, and commodities, with settlements in USDC. The past year saw $12.86 billion traded on its onchain orderbook, the introduction of native Ethereum Virtual Machine (EVM) compatibility, and significant institutional adoption.
Injective launched its native EVM on November 11, 2025, enabling Ethereum developers to deploy applications using familiar tools like MetaMask and Hardhat. This upgrade unified EVM and WebAssembly (WASM) apps under a single liquidity pool, eliminating the need for bridges or wrapped tokens. Transaction costs were reduced to fractions of a cent. Over 30 applications and infrastructure providers joined the network on day one.
Subsequent upgrades further enhanced the ecosystem. Chainlink Data Streams brought real-time pricing for U.S. stocks and ETFs in November 2025. In June 2026, the Vulcan upgrade reduced oracle update costs by 90% and added new data feeds for stocks and commodities. The September Meridian upgrade allowed regulated token issuance and streamlined EVM app transactions. In October, Injective published a new whitepaper outlining its vision as a finance-native blockchain, emphasizing real-world asset tokenization and institutional privacy through the upcoming CypherOS platform.
86 billion in onchain trading. 8 billion. Tokenized stock trading set monthly records from July to October, with September seeing a 16x increase in spot trading volume after governance reduced fees on flagship markets.
Source link







